Summary
Carbohydrate metabolism and insulin secretion in acromegaly have been studied by means of simulation and analogue analysis of plasma insulin and blood glucose curves obtained during OGTT in 20 acromegalic patients, using a model planned in our laboratory. Patients were arbitrarily subdivided into three groups according to blood glucose level at 120 min. Patients (8) with blood glucose level below or equal to 140 mg/100 ml were assigned to the first group; those (8) with blood glucose level ranging from 140 to 200 mg/100 ml were assigned to the second group; the remaining 4 patients with blood glucose level exceeding 200 mg/100 ml were assigned to the third group. Analogue simulation has shown that: 1) hepatic glycogenolysis is decreased in all patients; 2) peripheral glucose utilization is also decreased in all patients; 3) in the first group of patients, B-cell responsiveness to glucose and to gut hormones is increased; 4) in the second group, B-cell responsiveness to glucose is increased, whereas responsiveness to gut hormones is unchanged; 5) in the third group, B-cells still respond well to blood glucose variations but are not capable of reacting to high glycemic levels if these are constant; B-cell responsiveness to gut hormones remains normal; 6) insulin disappearance rate for biological purposes is decreased in all patients.
Similar content being viewed by others
References
Akerblom H. K., Newman P. R., Meaking J. W., Martin J. M., Simpson W. J. K.: Insulin and Growth Hormone Responses to Glucose Loading in Treated Acromegalics — Diabetologia5, 183, 1969.
Bastenie A. P.: Le diabète de l’acromégalie — Lille méd.9, 528, 1964.
Butterfield W. J. H., Garratt C. J., Rees J. R., Whichelow M. J.: Studies of Insulin Fixation in Vivo in Normal Subjects, Acromegalics and Diabetics, and its Effect on Local Glucose Metabolism — 4e Congrès Fed. Int. Diabète, Genève 1961. Ed. Médecine et Hygiène, Genève, 1971; vol. 1, p. 595.
Campbell J., Rastogi K. S.: Augmented Insulin Secretion due to Growth Hormone — Diabetes15, 749, 1966.
Cerasi E., Efendić S., Luft R.: Dose-Response Relation between Plasma Insulin and Blood Glucose Levels during Oral Glucose Loading in Prediabetic and Diabetic Subjects — Lancet2, 794, 1973.
Chisholm D. J., Lazarus L., Young J. D.: Secretin and Insulin Release in Acromegaly — J. clin. Endocr.35, 117, 1972.
Crepaldi G., Avogaro P., Tiengo A., Muggeo M., Enzi G., Federspil G., Trisotto A.: Le alterazioni del metabolismo glicidico nell’acromegalia e nella sindrome di Cushing — Atti Giornate Mediche Triestine, Trieste 1967.
Federspil G., Trisotto A., Scandellari C., Frezzato S., Lazzarin M., Turazzi S.: Utilizzazione del glucosio nell’acromegalia — Acta diabet. lat.6, 548, 1969.
Finenberg S. E., Merimee T. J., Rabinowitz D., Edgar P. J.: Insulin Secretion in Acromegaly — J. clin. Endocr.30, 288, 1970.
Goodman H. M.: A Comparative Study of the Effects of Insulin and Growth Hormone on Hexose Metabolism in Adipose Tissue — Endocrinology80, 45, 1967.
Goodman H. M.: Effects of Growth Hormone on Glucose Utilization in Diaphragm Muscle in the Absence of Increased Lipolysis — Endocrinology81, 1099, 1967.
Goodman H. M.: Growth Hormone and the Metabolism of Carbohydrate and Lipid in Adipose Tissue — Ann. N. Y. Acad. Sci.148, 419, 1968.
Hollobaugh S. L., Tzagournis M., Folk R. L., Kruger F. A., Hamwi G. J.: The Diabetogenic Action of Human Growth Hormone: Glucose-Fatty Acid Interrelationships — Metabolism17, 485, 1968.
Ikkos P., Luft R., Gemzell C. A.: The Effect of Homan Growth Hormone in Man — Acta endocr. (Kbh.)32, 341, 1959.
Karam J. H., Grodsky G. M., Pavlatos F., Forsham P. H.: Critical Factors in Excessive Serum-Insulin Response to Glucose. Obesity in Maturity-Onset Diabetes and Growth Hormone in Acromegaly — Lancet1, 286, 1965.
Luft R., Cerasi E.: Insulin Response to Glucose Infusion in Diabetic and Non Diabetic Monozygotic Twin-Pairs. Genetic Control of Insulin Response? — Acta endocr. (Kbh.)55, 330, 1967.
Luft R., Cerasi E.: Human Growth Hormone as a Regulator of Blood Glucose Concentration and as a Diabetogenic Substance — Diabetologia4, 1, 1968.
Luft R., Cerasi E., Hamberger C. A.: Studies on the Pathogenesis of Diabetes in Acromegaly — Acta endocr. (Kbh.)56, 593, 1967.
Martin J. M., Gagliardino J. J.: Effect of Growth Hormone on the Isolated Pancreatic Islets of the Rat in Vitro — Nature (Lond.)213, 630, 1967.
Sirotich G., Federspil G., Framarin F.: An Analogue Model of the Blood Glucose and Serum Insulin Response to the Oral Glucose Tolerance Test — Acta diabet. lat.7, 1004, 1970.
Sönksen P. H., Greenwood F. C., Ellis J. P., Lowy C., Rutherford A., Nabarro J. D. N.: Changes of Carbohydrate Tolerance in Acromegaly with Progress of the Disease and in Response to Treatment — J. clin. Endocr.27, 1418, 1967.
Tepperman J.: Metabolic and Endocrine Physiology — 2nd Ed. Year Book Med. Publ., Inc., Chicago, 1968.
Tiengo A., Crepaldi G., Muggeo M., Fellin R., Federspil G., Trisotto A., Frezzato S.: Il comportamento dell’insulinemia (IRI) nell’acromegalia — Acta isotop.7, 377, 1967.
Vinik A. I., Kalk W. J., Keller P., Beumont P., Jackson W. P. V.: Overactivity of the Enteroinsular Axis in Maturity-Onset Diabetes — Lancet2, 183, 1973.
Author information
Authors and Affiliations
Additional information
This study was supported by C.N.R. grant: reference n. 72.00636.04.
Istituto di Biologia Animale dell’Università di Padova.
Rights and permissions
About this article
Cite this article
Scandellari, C., Casara, D., Zaccaria, M. et al. Analogue analysis of oral glucose tolerance test and insulin secretion in acromegaly. Acta diabet. lat 11, 61–70 (1974). https://doi.org/10.1007/BF02581940
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581940